Friday, 1 March 2013

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial | BMJ

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial Schierbeck et al BMJ 2012;345:e6409
Conclusions After 10 years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure, or myocardial infarction, without any apparent increase in risk of cancer, venous thromboembolism, or stroke.
They used bio-identicals you see, not cheaper, artificial estrogen-like compounds as with other studies.

2 comments:

M Italiano said...

Hi Zoe, Thanks or this link. Being an alternative/holistic medicine physician I can only prescribe bioidentical hormones. The US FDA and other agencies are trying hard to push the synthetics. It is
about $ and what is patentable and they do not care what happens to the patients. I think that the synthetic hormones are dangerous and I do not recommend them. Every hormone that you can think of is available as a bioidentical hormone
and can be made just as potent.

Ryan Clark said...
This comment has been removed by a blog administrator.